Shanghai Stock Analysis

Professionals Have Reviewed Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. (603707)’s Latest Trading Session (2019-07-10)

Our first news is we have found two fantastic resources that should be of major interest to Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. investors (one about an undiscovered $3 stock that offers major potential, and one for a powerful new investment system) – we strongly recommend Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. (603707) investors take a look. Take your time with these:

http://tallahasseescene.com/presentation-for-SHANGHAI603707-investors

http://tallahasseescene.com/investing-system-for-SHANGHAI603707-investors

REPORTING FOR 2019-07-10 | TALLAHASSEESCENE.COM: We have conducted a deep analysis of how Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. (603707) has been trading over the last 2 weeks and the past day especially. On its latest session, Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. (603707) opened at 26.9692, reaching a high of 27.7615 and a low of 26.1539 before closing at a price of 27.2231. There was a total volume of 3606399.0.

VOLUME INDICATORS: We saw an accumulation-distribution index of 152.05537, an on-balance volume of 27.3846, chaikin money flow of 3.05806 and a force index of 0.36209. There was an ease of movement rating of -0.02906, a volume-price trend of 2.49151 and a negative volume index of 1000.0.

VOLATILITY: We noted an average true range of 0.71243, bolinger bands of 27.93546, an upper bollinger band of 25.30304, lower bollinger band of 26.1539, a bollinger high band indicator of 1.0, bollinger low band indicator of 1.0, a central keltner channel of 26.96153, high band keltner channel of 26.16923, low band keltner channel of 27.75383, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 26.1539, a donchian channel low band of 26.1539, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.

TREND: We calculated a Moving Average Convergence Divergence (MACD) of 0.02088, a MACD signal of 0.0116, a MACD difference of 0.00928, a fast Exponential Moving Average (EMA) indicator of 26.1539, a slow Exponential Moving Average (EMA) indicator of 26.1539, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.38374, a trix of 3.38394, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of -2.25813, a KST Oscillator (KST) of 94.49924 and a KST Oscillator (KST Signal) of 94.49924 (leaving a KST difference of 9.73708). We also found an Ichimoku rating of 27.36535, an Ichimoku B rating of 27.36535, a Ichimoku visual trend A of 25.58042, an Ichimoku visual trend B of 25.74699, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of 4.0.

MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 100.0, a True Strength Index (TSI) of 100.0, an ultimate oscillator of 73.47265, a stochastic oscillator of 202.90294, a stochastic oscillator signal of 202.90294, a Williams %R rating of 102.90294 and an awesome oscillator of 0.09706.

RETURNS: There was a daily return of 9.44992, a daily log return of 3.4967 and a cumulative return of 3.55855.

What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-10 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. (603707)…

To stay up to date with what is happening here, we strongly advise Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on stocks like Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. – without this you are trading blind:

We will of course continue to cover the news and price action of Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd., but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.

DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling Nanjing King-friend Biochemical Pharmaceutical Co.,Ltd. (603707) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.

Abigale Lormen

Abigale is a Masters in Business Administration by education. After completing her post-graduation, Abigale jumped the journalism bandwagon as a freelance journalist. Soon after that she landed a job of reporter and has been climbing the news industry ladder ever since to reach the post of editor at Tallahasseescene.
Abigale Lormen

Latest posts by Abigale Lormen (see all)